Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node, Cardiovascular Research (2024) Semaglutide and cardiovascular outcomes in obesity without diabetes, The New England Journal of Medicine (2023) Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme, Diabetes, Obesity and Metabolism (2024) Ozempic (semaglutide injection) product monograph (2018) Tachycardia, Mayo Clinic (2023) How to check your heart rate (manually and using a device), Mass General Brigham (2025) Target Heart Rates Chart, American Heart Association (2025) Craig D
Undeterred, Knudsen plunged straight back into tweaking the peptide, which she says the company's management gave 'only one more shot' (Molteni)
It has been hailed as a breakthrough for individuals struggling with obesity or diabetes, offering an effective way to control these conditions
This guide walks Miami and South Florida patients through that evidence and the practical clinical decisions it supports
Glutathione for Skin: IV vs
A systematic review of literature and meta-analysis